Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v15-EN | Version v2-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2024-03-29 | 2024-02-16 |
| Drug Identification Number | 02436442 | 02436442 |
| Brand name | PNEUMOVAX 23 | PNEUMOVAX 23 |
| Common or Proper name | (pneumococcal vaccine, polyvalent) Solution for injection | (pneumococcal vaccine, polyvalent) Solution for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 |
| Strength(s) | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR | SUBCUTANEOUS INTRAMUSCULAR |
| Packaging size | 10X1DOSE SYRINGE | 10X1DOSE SYRINGE |
| ATC code | J07AL | J07AL |
| ATC description | ||
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2024-03-11 | 2024-02-19 |
| Actual start date | 2024-03-04 | |
| Estimated end date | 2024-03-31 | 2024-03-31 |
| Actual end date | 2024-03-28 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Remaining doses are reserved for the public immunization program. | Remaining doses are reserved for the public immunization program. |
| Health Canada comments |